2004
DOI: 10.1038/nri1457
|View full text |Cite
|
Sign up to set email alerts
|

Ido expression by dendritic cells: tolerance and tryptophan catabolism

Abstract: Indoleamine 2,3-dioxygenase (IDO) is an enzyme that degrades the essential amino acid tryptophan. The concept that cells expressing IDO can suppress T-cell responses and promote tolerance is a relatively new paradigm in immunology. Considerable evidence now supports this hypothesis, including studies of mammalian pregnancy, tumour resistance, chronic infections and autoimmune diseases. In this review, we summarize key recent developments and propose a unifying model for the role of IDO in tolerance induction.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

43
1,953
8
27

Year Published

2007
2007
2014
2014

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 2,079 publications
(2,052 citation statements)
references
References 149 publications
43
1,953
8
27
Order By: Relevance
“…24 The overexpression of IDO can suppress immune responses by blocking T-cell proliferation locally, 25 and its activity can be inhibited by the competitive inhibitor 1-MT. 26 In our experiments, 1-MT could marginally restore IFN-c production, suggesting that the suppressive effect of PF is mediated by IDO and additional soluble factors.…”
Section: Pf Inhibits the Functions Of T Cells And Differentiation Of mentioning
confidence: 46%
“…24 The overexpression of IDO can suppress immune responses by blocking T-cell proliferation locally, 25 and its activity can be inhibited by the competitive inhibitor 1-MT. 26 In our experiments, 1-MT could marginally restore IFN-c production, suggesting that the suppressive effect of PF is mediated by IDO and additional soluble factors.…”
Section: Pf Inhibits the Functions Of T Cells And Differentiation Of mentioning
confidence: 46%
“…11 Immunostaining for IDO in the different organs demonstrated higher numbers of IDO þ cells in B cell-(GC staining) and T-cell areas of Mes LNs than in the other organs, as well as higher levels in Mes LNs of macaques progressing faster to AIDS (Figures 2b and d). Similar to TGF-b, we found greater numbers of IDO þ cells in the GALT of non-controllers than in controllers (Figure 3b).…”
Section: Resultsmentioning
confidence: 93%
“…It has been also shown that IDO is strongly expressed in macrophages and dendritic cells (DCs). 11 Herein, IDO immunostaining identified cells displaying a non-lymphoid morphological phenotype (Figure 2b). Thus, our data identified IDO and TGF-b in the lymphoid tissues as potential markers for AIDS progression, and these mediators might contribute to a significant extent to immunosuppression or blunting the local antiviral defenses.…”
Section: Resultsmentioning
confidence: 98%
See 1 more Smart Citation
“…High expression of IDO results in an immunosuppressive tumor microenvironment with impaired activity of effector T cells, increased differentiation of regulatory T (T reg ) cells and decreased dendritic cell (DC) functions. 26 Treatment with IDO inhibitor reversed suppression by decreasing numbers of myeloid-derived suppressor cells (MDSCs) and T reg s. 27 Expression of IDO is a critical resistance mechanism to CTLA-4 blockade and dual inhibition with CTLA-4 and PD-1 or PD-L1 blockade leads to synergistic antitumor effects in melanoma models. 28,29 Therefore, preclinical data provides a strong theoretical basis for exploration of clinical combinations of IDO inhibitors and immune checkpoint inhibitors.…”
Section: Combination Strategiesmentioning
confidence: 99%